<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">17069648</PMID>
        <DateCompleted>
            <Year>2007</Year>
            <Month>01</Month>
            <Day>04</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1466-609X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2006</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Critical care (London, England)</Title>
                <ISOAbbreviation>Crit Care</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The effects of continuous venovenous hemofiltration on coagulation activation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>R150</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The mechanism of coagulation activation during continuous venovenous hemofiltration (CVVH) has not yet been elucidated. Insight into the mechanism(s) of hemostatic activation within the extracorporeal circuit could result in a more rational approach to anticoagulation. The aim of the present study was to investigate whether CVVH using cellulose triacetate filters causes activation of the contact factor pathway or of the tissue factor pathway of coagulation. In contrast to previous studies, CVVH was performed without anticoagulation.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Ten critically ill patients were studied prior to the start of CVVH and at 5, 15 and 30 minutes and 1, 2, 3 and 6 hours thereafter, for measurement of prothrombin fragment F1+2, soluble tissue factor, activated factor VII, tissue factor pathway inhibitor, kallikrein-C1-inhibitor and activated factor XII-C1-inhibitor complexes, tissue-type plasminogen activator, plasminogen activator inhibitor type I, plasmin-antiplasmin complexes, protein C and antithrombin.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">During the study period the prothrombin fragment F1+2 levels increased significantly in four patients (defined as group A) and did not change in six patients (defined as group B). Group A also showed a rapid increase in transmembrane pressure, indicating clotting within the filter. At baseline, the activated partial thromboplastin time, the prothrombin time and the kallikrein-C1-inhibitor complex and activated factor XII-C1-inhibitor complex levels were significantly higher in group B, whereas the platelet count was significantly lower in group B. For the other studied markers the differences between group A and group B at baseline were not statistically significant. During CVVH the difference in the time course between group A and group B was not statistically significant for the markers of the tissue factor system (soluble tissue factor, activated factor VII and tissue factor pathway inhibitor), for the markers of the contact system (kallikrein-C1-inhibitor and activated factor XII-C1-inhibitor complexes) and for the markers of the fibrinolytic system (plasmin-antiplasmin complexes, tissue-type plasminogen activator and plasminogen activator inhibitor type I).</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Early thrombin generation was detected in a minority of intensive care patients receiving CVVH without anticoagulation. Systemic concentrations of markers of the tissue factor system and of the contact system did not change during CVVH. To elucidate the mechanism of clot formation during CVVH we suggest that future studies are needed that investigate the activation of coagulation directly at the site of the filter. Early coagulation during CVVH may be related to lower baseline levels of markers of contact activation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bouman</LastName>
                    <ForeName>Catherine S C</ForeName>
                    <Initials>CS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Intensive Care, Academic Medical Center, University of Amsterdam, PO 22660, 1100 DD Amsterdam, The Netherlands. c.s.bouman@amc.uva.nl</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Pont</LastName>
                    <ForeName>Anne-Corn√©lie J M</ForeName>
                    <Initials>AC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meijers</LastName>
                    <ForeName>Joost C M</ForeName>
                    <Initials>JC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bakhtiari</LastName>
                    <ForeName>Kamran</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roem</LastName>
                    <ForeName>Dorina</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zeerleder</LastName>
                    <ForeName>Sacha</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wolbink</LastName>
                    <ForeName>Gertjan</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Korevaar</LastName>
                    <ForeName>Johanna C</ForeName>
                    <Initials>JC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Levi</LastName>
                    <ForeName>Marcel</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Jonge</LastName>
                    <ForeName>Evert</ForeName>
                    <Initials>E</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Crit Care</MedlineTA>
            <NlmUniqueID>9801902</NlmUniqueID>
            <ISSNLinking>1364-8535</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D001779">Blood Coagulation Factors</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001779" MajorTopicYN="N">Blood Coagulation Factors</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006440" MajorTopicYN="Y">Hemofiltration</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2006</Year>
                <Month>06</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2006</Year>
                <Month>09</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2006</Year>
                <Month>10</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2006</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2007</Year>
                <Month>1</Month>
                <Day>5</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2006</Year>
                <Month>10</Month>
                <Day>31</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">17069648</ArticleId>
            <ArticleId IdType="pii">cc5080</ArticleId>
            <ArticleId IdType="doi">10.1186/cc5080</ArticleId>
            <ArticleId IdType="pmc">PMC1751049</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Appl Thromb Hemost. 2005 Jan;11(1):37-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15678271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thromb Haemost. 1999 Sep;82(3):1041-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10494761</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2005 Aug 17;294(7):813-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16106006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care. 2006;10(2):R45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16542495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care Med. 2000 Feb;28(2):421-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10708177</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Thromb Hemost. 2000;26(1):39-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10805280</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Contrib Nephrol. 2001;(132):283-303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11395897</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care Med. 2001 Jul;29(7 Suppl):S48-51; discussion 51-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11445734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 2003 Jul;29(7):1205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12761613</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2004 Jan;19(1):164-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14671052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thromb Res. 1984 Oct 15;36(2):177-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6506035</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Care Med. 1985 Oct;13(10):818-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3928249</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thromb Res. 1987 Aug 15;47(4):389-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3499007</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 1988 Dec;72(6):1841-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3264190</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann N Y Acad Sci. 1992 Dec 4;667:454-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1309069</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ASAIO J. 1995 Jul-Sep;41(3):M790-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8573916</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunopharmacology. 1996 May;32(1-3):57-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8796267</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anaesth Intensive Care. 1996 Aug;24(4):423-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8862637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intensive Care Med. 1997 Jan;23(1):38-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9037638</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Kidney Dis. 1997 Nov;30(5 Suppl 4):S20-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9372975</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S9-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9819023</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood Purif. 1998;16(5):261-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9917534</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 1999 Apr;55(4):1568-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10201024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Biochem. 1999 Aug;263(3):904-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10469157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Artif Organs. 1999 Jul;22(7):482-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10493555</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 2005 Jun;67(6):2361-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15882280</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>